# Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants

> **NCT00767039** · PHASE4 · TERMINATED · sponsor: **Alan Fujii** · enrollment: 52 (actual)

## Conditions studied

- Prematurity
- Respiratory Distress Syndrome
- Patent Ductus Arteriosus

## Interventions

- **DRUG:** Survanta (beractant)
- **DRUG:** Curosurf (poractant)

## Key facts

- **NCT ID:** NCT00767039
- **Lead sponsor:** Alan Fujii
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-01
- **Primary completion:** 2008-09
- **Final completion:** 2009-01
- **Target enrollment:** 52 (ACTUAL)
- **Why stopped:** Slow recruitment,changes in protocols, larger than anticipated differences
- **Last updated:** 2011-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00767039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00767039, "Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT00767039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*